BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27807862)

  • 41. High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer.
    Mei H; Lian S; Zhang S; Wang W; Mao Q; Wang H
    Biochem Biophys Res Commun; 2014 Oct; 453(4):703-9. PubMed ID: 25301559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma.
    Lan F; Zhang L; Wu J; Zhang J; Zhang S; Li K; Qi Y; Lin P
    Int J Colorectal Dis; 2011 Dec; 26(12):1511-8. PubMed ID: 21547355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer.
    Sullivan S; Tosetto M; Kevans D; Coss A; Wang L; O'Donoghue D; Hyland J; Sheahan K; Mulcahy H; O'Sullivan J
    Int J Cancer; 2009 Jul; 125(1):54-61. PubMed ID: 19291794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
    Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
    Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
    Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
    Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Over-expression of the overexpressed in lung cancer-1 is associated with poor prognosis in colorectal cancer.
    Liu J; Song H; Yao L; Liu Y; Zhang Y; Zhao H; Ji H; Wang Y
    Anticancer Res; 2014 Jan; 34(1):367-72. PubMed ID: 24403489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
    Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
    Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
    Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
    Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
    Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer.
    Spindler KG; Demuth C; Sorensen BS; Johansen JS; Nielsen D; Pallisgaard N; Hoegdall E; Pfeiffer P; Vittrup Jensen B
    Tumour Biol; 2018 Nov; 40(11):1010428318811207. PubMed ID: 30486767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placenta growth factor expression is correlated with survival of patients with colorectal cancer.
    Wei SC; Tsao PN; Yu SC; Shun CT; Tsai-Wu JJ; Wu CH; Su YN; Hsieh FJ; Wong JM
    Gut; 2005 May; 54(5):666-72. PubMed ID: 15831913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of prognostic significance of SOCS-1 expression in colorectal adenocarcinomas.
    Ayyildiz T; Dolar E; Adim SB; Eminler AT; Yerci O
    Asian Pac J Cancer Prev; 2014; 15(19):8469-74. PubMed ID: 25339048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.
    Wang L; Liu Z; Fisher KW; Ren F; Lv J; Davidson DD; Baldridge LA; Du X; Cheng L
    Hum Pathol; 2018 Jan; 71():20-29. PubMed ID: 28782638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
    Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
    J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer.
    Kwon KA; Yun J; Oh SY; Seo BG; Lee S; Lee JH; Kim SH; Choi HJ; Roh MS; Kim HJ
    Cancer Res Treat; 2016 Jan; 48(1):198-207. PubMed ID: 26130665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer.
    Maaser K; Grabowski P; Sutter AP; Höpfner M; Foss HD; Stein H; Berger G; Gavish M; Zeitz M; Scherübl H
    Clin Cancer Res; 2002 Oct; 8(10):3205-9. PubMed ID: 12374690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.